Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer

被引：0
|
作者：
Chua, G. W. Y. [1 ]
Tan, D. B. H. [1 ]
Tay, G. H. [1 ]
Foo, Y. W. [1 ]
机构：
[1] Natl Canc Ctr Singapore, Dept Radiat Oncol, Singapore, Singapore
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)31282-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV-0033
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 50 条
  • [21] HIGH DOSE-RATE INTRACAVITARY BRACHYTHERAPY IN ELDERLY WOMEN WITH CERVICAL CANCER
    Melo, M.
    Novaes, P.
    Balloni, H.
    Teixeira, G.
    Castro, D.
    Salvajoli, J. V.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S186 - S187
  • [22] Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer
    Itami, Jun
    Murakami, Naoya
    Watanabe, Miho
    Sekii, Shuhei
    Kasamatsu, Takahiro
    Kato, Shingo
    Hirowatari, Hisako
    Ikushima, Hitoshi
    Ando, Ken
    Ohno, Tatsuya
    Okamoto, Hiroyuki
    Okuma, Kae
    Igaki, Hiroshi
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [23] Analysis of Lymph Node Control in Patients Treated With Whole-Pelvic Radiation and Intracavitary Brachytherapy Without Lymph Node Boost for Uterine Cervical Cancer
    Kim, H.
    Huh, S. J.
    Park, W.
    Noh, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E277 - E277
  • [24] Parametrial spread of cervical cancer in patients with negative pelvic lymph nodes
    Winter, R
    Haas, J
    Reich, O
    Koemetter, R
    Tamussino, K
    Lahousen, M
    Petru, E
    Pickel, H
    GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 252 - 257
  • [25] Human Papillomavirus DNA Presence in Pelvic Lymph Nodes in Cervical Cancer
    Slama, Jiri
    Fischerova, Daniela
    Pinkavova, Ivana
    Zikan, Michal
    Cibula, David
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (01) : 126 - 132
  • [26] Evaluation of variation in dose of organs at risk in intracavitary brachytherapy of cervical cancer - a prospective study
    Sharma, Brahmacharimayum Arunkumar
    Singh, Tomcha
    Singh, L. Jaichand
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2011, 3 (01) : 23 - 25
  • [27] Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy
    Siavashpour, Zahra
    Aghamiri, Mahmoud Reza
    Jaberi, Ramin
    Manshadi, Hamid Reza Dehghan
    Ghaderi, Reza
    Kirisits, Christian
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2016, 8 (02) : 135 - 142
  • [28] Factors affecting the dosimetry of high-dose rate intracavitary brachytherapy in cervical cancer
    Mahapatra, Bikash Ranjan
    Barik, Sandip Kumar
    Das, Deepak Kumar
    Das Majumdar, Saroj Kumar
    Parida, Dillip Kumar
    Ramasubbu, Mathan Kumar
    Badajena, Avinash
    Barik, Bijay Kumar
    Mishra, Minakshi
    Pattanaik, Ashutosh
    Kanungo, Satyabrata
    Muraleedharan, Anupam
    Ahmed, Sk Soel
    Mukherjee, Priyanka
    Abdulla, Shaha Sheik
    Mahajan, Ankur
    Sarkar, Arnab
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2024, 23
  • [29] Delivering Intracavitary/Interstitial Brachytherapy Equivalent Dose Distributions with An Intracavitary-Only Helical Rotating Shield Brachytherapy Approach for Cervical Cancer Treatment
    Hopfensperger, K.
    Adams, Q.
    Kim, Y.
    Wu, X.
    Xu, W.
    Patwardhan, K.
    Thammavong, B.
    Flynn, R.
    MEDICAL PHYSICS, 2019, 46 (06) : E493 - E494
  • [30] Assessment of the Anatomical Position of Point B and the Relationship Between Point B Dose and the Dose Delivered to Pelvic Lymph Nodes in CT-Based HDR Brachytherapy for Uterine Cervical Cancer
    Matsukawa, H.
    Sasaki, T.
    Hirayama, R.
    Hirose, T.
    Fukunaga, J.
    MEDICAL PHYSICS, 2018, 45 (06) : E245 - E245
12345